Cardioprotection, attenuated systemic inflammation, and survival benefit of β1-adrenoceptor blockade in severe sepsis in rats*
- 1 February 2010
- journal article
- Published by Ovid Technologies (Wolters Kluwer Health) in Critical Care Medicine
- Vol. 38 (2), 388-394
- https://doi.org/10.1097/ccm.0b013e3181c03dfa
Abstract
To explore the hypothesis that beta-1 adrenoreceptor blockade may be protective through the attenuation of sympathetic hyperactivity and catecholaminergic inflammatory effects on cardiac and hepatic function. Prospective, randomized, controlled study. Animal laboratory in a university medical center. Male adult Wistar rats. Peripheral beta1-adrenoceptor blockade through daily intraperitoneal injection (metoprolol, 100 mg x kg(-1); atenolol, 6 mg x kg(-1)) or central nervous system beta1-adrenoceptor blockade (intracerebroventricular metoprolol, 25 microg) to achieve approximately 20% heart rate reduction in rats for 2 days before or after the induction of lethal endotoxemia, cecal ligation and puncture, or fecal peritonitis. Peripheral beta1-adrenoceptor blockade established for 2 days before lethal endotoxemia markedly improved survival in both metoprolol-treated (n = 16; log rank test, p = .002) and atenolol-treated (n = 15; p = .03) rats. Overall mortality in cecal ligation and puncture was similar between metoprolol (40%; n = 10) and saline (50%; n = 10) pretreatment (p = .56), but the median time to death was increased by 33 hrs in metoprolol-treated rats (p = .03). Metoprolol pretreatment reduced hepatic expression of proinflammatory cytokines and lowered plasma interleukin-6 (both p < .05). Myocardial protein expression of interleukin-18 and monocyte chemoattractant protein-1, key mediators of cardiac dysfunction in sepsis, were also reduced (p < .05). Peripheral beta1-adrenoceptor blockade commenced 6 hrs after lethal endotoxemia or fecal peritonitis did not improve survival. However, arterial blood pressure was preserved and left ventricular contractility restored similar to that found in nonseptic controls. Central nervous system beta1-adrenoceptor blockade (metoprolol) did not reduce plasma cytokines or mortality, despite enhancing parasympathetic tone. Peripheral beta1-adrenoceptor blockade offers anti-inflammatory and cardioprotective effects, with mortality reduction if commenced before a septic insult. Its role in sepsis should be explored further.Keywords
This publication has 38 references indexed in Scilit:
- Catecholamines induce an inflammatory response in human hepatocytesCritical Care Medicine, 2008
- Physiology and immunology of the cholinergic antiinflammatory pathwayJCI Insight, 2007
- Propranolol ameliorates and epinephrine exacerbates progression of acute and chronic viral myocarditisAmerican Journal of Physiology-Heart and Circulatory Physiology, 2005
- Impact of prolonged elevated heart rate on incidence of major cardiac events in critically ill patients with a high risk of cardiac complications*Critical Care Medicine, 2005
- Mitochondrial dysfunction in a long-term rodent model of sepsis and organ failureAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2004
- Stroke-induced Immunodeficiency Promotes Spontaneous Bacterial Infections and Is Mediated by Sympathetic Activation Reversal by Poststroke T Helper Cell Type 1–like ImmunostimulationThe Journal of Experimental Medicine, 2003
- β-Adrenergic Blockade in Developing Heart FailureCirculation, 2000
- Clinical Effects of β-Adrenergic Blockade in Chronic Heart FailureCirculation, 1998
- RETRACTED ARTICLE: Alterations in circulating vasoactive substances in the critically ill —a comparison between survivors and non-survivorsIntensive Care Medicine, 1995
- Increased beta-receptor density and improved hemodynamic response to catecholamine stimulation during long-term metoprolol therapy in heart failure from dilated cardiomyopathy.Circulation, 1989